The Stanford Cancer Cell Therapy and Blood and Marrow Transplant Symposium will address the current and future state of blood and marrow transplantation and cancer cell therapy to aid participants in their clinical decision making. This hybrid conference offers a review of the latest advances in blood marrow transplantation and cancer cell therapy, including clinical trials research and future approaches on treatment strategies to optimize patients’ clinical outcomes. This year, our symposium will be honoring Dr. Robert Negrin and his years of service as Chief of the Stanford Blood and Marrow Transplantation – Cell Therapy Division. Please join us in recognizing Dr. Negrin’s impactful contributions to the field of Blood and Marrow Transplantation.

Registration fee includes course materials, certificate of participation, breakfast and lunch.  The symposium is a hybrid activity; you can attend in person or virtually.  Please select the corresponding registration type when registering.

Early Bird Rate:
Physicians (in person) – $250
Physicians (virtual) – $250
Nurses/Allied Health Professionals (in person) – $200
Nurses/Allied Health Professionals (virtual) – $200

After 3/10/2022
Physicians (in person) – $300
Physicians (virtual) – $300
Nurses/Allied Health Professionals (in person) – $250
Nurses/Allied Health Professionals (virtual) – $250

Registration may be paid by Visa, MasterCard or check. If you prefer to pay by phone or check, please contact the Stanford Center for CME at (650) 497-8554 for assistance.

STAP-eligible employees can use STAP funds towards the registration fees for this activity.  Complete the STAP Reimbursement Request Form and submit to your department administrator.

Your email address is used for critical information, including registration confirmation, evaluation, and certificate. Be sure to include an email address that you check frequently.

AMA PRA Category 1 Credits™ (12.50 hours), Non-Physician Participation Credit (12.50 hours)

1. Discuss the importance of stem cell niche in allogeneic hematopoietic cell engraftment.
2. Examine how to find suitable allogeneic donor(s) for all patients.
3. Interpret the role of regulatory T cells (Treg) in graft-versus-host disease.
4. Analyze the novel concept of graft engineering in improving clinical outcomes in allogeneic transplant.
5. Review the application of cellular therapy in managing autoimmune disease and inducing tolerance.
6. Review the state-of-art report on the utility of CART cells in B-cell malignancies.
7. Discuss the development of CART cell therapy in myeloid malignancies.
8. Examine the utility of CART cell therapy in solid tumor including sarcoma.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA)
Stanford Medicine designates this Live Activity for a maximum of 12.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Cancellation Policy
Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to stanfordcme@stanford.edu.

Stanford University School of Medicine reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For activity related questions, please contact
Name: Melissa Schwartz
Title: Events Project Manager
Email: Melissa.schwartz@stanford.edu

For CME general questions, please contact
    Email: stanfordcme@stanford.edu